Development and Validation of a Prognostic Autophagy-Related Gene Pair Index Related to Tumor-Infiltrating Lymphocytes in Early-Stage Lung Adenocarcinoma.
Development and Validation of a Prognostic Autophagy-Related Gene Pair Index Related to Tumor-Infiltrating Lymphocytes in Early-Stage Lung Adenocarcinoma.
复制标题
与早期肺腺癌肿瘤浸润淋巴细胞相关的预后自噬相关基因对指数的开发和验证
DOI:
10.3389/fcell.2021.719011
复制
发表时间:
2021
影响因子:
5.5
通讯作者:
Zhou Q
中科院分区:
文献类型:
--
作者:
Wang ZH;Li Y;Zhang P;Xiang X;Wei XS;Niu YR;Ye LL;Peng WB;Zhang SY;Xue QQ;Zhou Q
The role of autophagy in lung cancer is context-dependent and complex. Recent studies have reported the important role of autophagy in tumor immune escape. However, the association between autophagy and tumor-infiltrating lymphocytes (TILs) in early-stage lung adenocarcinoma (LUAD) remains unclear. In this study, we aimed to develop and validate the autophagy-related gene pair index (ATGPI) and autophagy clinical prognostic index (ACPI) in multiple LUAD cohorts, including The Cancer Genome Atlas (TCGA) cohort, Gene Expression Omnibus cohorts, and one cohort from Union Hospital, Wuhan (UH cohort), using a Cox proportional hazards regression model with the least absolute shrinkage and selection operator. Multivariate Cox regression analysis demonstrated that there was a significant difference in overall survival (OS) between patients with high and low ATGPI in the testing [hazard ratio (HR) = 1.97;P< 0.001] and TCGA validation (HR = 2.25;P< 0.001) cohorts. Time-dependent receiver operating characteristic curve analysis was also performed. We found that high ATGPI could accurately identify patients with early-stage LUAD with shorter OS, with the areas under the curve of 0.703 and 0.676 in the testing and TCGA validation cohorts, respectively. Concordance index (C-index) was used to evaluate the efficiency of ATGPI and ACPI. The C-index of ACPI was higher than that of ATGPI in the testing (0.71 vs. 0.66;P< 0.001), TCGA validation (0.69 vs. 0.65;P= 0.028), and UH (0.80 vs. 0.70;P= 0.015) cohorts. TIL analysis demonstrated that the proportions of tumor-infiltrating CD4+T cells were lower in the high-ATGPI group than in the low-ATGPI group in both the TCGA validation and UH cohorts. These results indicate the potential clinical use of ATG signatures which are associated with TILs, in identifying patients with early-stage LUAD with different OS.
登录
查看更多内容
影响因子:
29
作者:
Kimmelman AC;White E
通讯作者:
White E
DOI:
10.1002/path.5096
发表时间:
2018-08
期刊:
The Journal of pathology
影响因子:
--
作者:
Martínez-Terroba E;Behrens C;de Miguel FJ;Agorreta J;Monsó E;Millares L;Sainz C;Mesa-Guzman M;Pérez-Gracia JL;Lozano MD;Zulueta JJ;Pio R;Wistuba II;Montuenga LM;Pajares MJ
通讯作者:
Pajares MJ
影响因子:
15.8
作者:
Gong, Yixuan;Somwar, Romel;Politi, Katerina;Balak, Marissa;Chmielecki, Juliann;Jiang, Xuejun;Pao, William
通讯作者:
Pao, William
影响因子:
10.3
作者:
Ajona, Daniel;Pajares, Maria J.;Pio, Ruben
通讯作者:
Pio, Ruben
影响因子:
8
作者:
Liang, M-C;Ma, J.;Chen, L.;Kozlowski, P.;Qin, W.;Li, D.;Goto, J.;Shimamura, T.;Hayes, D. N.;Meyerson, M.;Kwiatkowski, D. J.;Wong, K-K
通讯作者:
Wong, K-K